The LIBERATE tibolone trial in breast cancer survivors

Maturitas. 2009 May 20;63(1):1-3. doi: 10.1016/j.maturitas.2009.03.001. Epub 2009 Mar 26.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms* / chemically induced
  • Contraindications
  • Estrogen Receptor Modulators* / adverse effects
  • Estrogen Replacement Therapy* / adverse effects
  • Female
  • Humans
  • Norpregnenes* / adverse effects
  • Postmenopause
  • Randomized Controlled Trials as Topic
  • Survivors

Substances

  • Estrogen Receptor Modulators
  • Norpregnenes
  • tibolone